Literature DB >> 10377107

Histoplasma capsulatum strain variation in both H antigen production and beta-glucosidase activity and overexpression of HAG1 from a telomeric linear plasmid.

K L Fisher1, G S Deepe, J P Woods.   

Abstract

The H antigen of the dimorphic fungal pathogen Histoplasma capsulatum was first described over 40 years ago. It is a secreted glycoprotein that is immunogenic during infection. Recent cloning of the H antigen gene (HAG1) indicated sequence homology with genes for fungal beta-glucosidases. To understand the biological role of this immunodominant antigen in H. capsulatum, enzymatic assays were performed to determine whether H. capsulatum contained a beta-glucosidase enzyme activity and whether this activity was encoded by the HAG1 gene. Substrate gels with H. capsulatum culture supernatants revealed beta-glucosidase activity near the predicted mobility of the H antigen. Quantitative microtiter plate assays revealed marked differences in secreted beta-glucosidase activities from three H. capsulatum restriction fragment length polymorphism (RFLP) classes, with RFLP class II strains displaying high levels of enzyme activity, in contrast to the low levels of activity exhibited by class I and III strains. Immunoblotting of culture supernatants with an H antigen-specific antiserum demonstrated differences in H protein expression levels between the H. capsulatum classes, with a correlation between secreted enzyme activity and H protein levels. We took advantage of these class differences to demonstrate multicopy plasmid H gene overexpression by transformation of an HAG1 plasmid into H. capsulatum. Both a class II strain (G217Bura5-23) and a class III strain (G184ASura5-11) transformed with the telomeric overexpression plasmid pMAD401 displayed increased levels of beta-glucosidase enzyme activity and H protein expression compared to the levels in control transformants containing only the single genomic copy of HAG1. This is the first demonstration of telomeric plasmid-mediated protein overexpression in this pathogenic fungus, and the findings support the identification of the H antigen as a beta-glucosidase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377107      PMCID: PMC116512     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Diagnosis of histoplasmosis using precipitin reactions in agargel.

Authors:  D C HEINER
Journal:  Pediatrics       Date:  1958-10       Impact factor: 7.124

2.  Cell wall studies of Histoplasma capsulatum and Blastomyces dermatitidis using autologous and heterologous enzymes.

Authors:  T E Davis; J E Domer; Y T Li
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Histoplasmosis. An illustrative case with unusual vaginal and joint involvement.

Authors:  M Gass; G S Kobayashi
Journal:  Arch Dermatol       Date:  1969-12

4.  The mycelial status and reversibility in Histoplasma capsulatum.

Authors:  R Borok
Journal:  Sabouraudia       Date:  1980-12

5.  Classification of Histoplasma capsulatum isolates by restriction fragment polymorphisms.

Authors:  R D Vincent; R Goewert; W E Goldman; G S Kobayashi; A M Lambowitz; G Medoff
Journal:  J Bacteriol       Date:  1986-03       Impact factor: 3.490

6.  Purification, composition, and serological characterization of histoplasmin-H and M antigens.

Authors:  G Bradley; L Pine; M W Reeves; C W Moss
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

7.  In vivo generation of linear plasmids with addition of telomeric sequences by Histoplasma capsulatum.

Authors:  J P Woods; W E Goldman
Journal:  Mol Microbiol       Date:  1992-12       Impact factor: 3.501

8.  Isolation and characterization of spontaneous avirulent variants of Histoplasma capsulatum.

Authors:  K R Klimpel; W E Goldman
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

9.  Immunobiological activity of recombinant H antigen from Histoplasma capsulatum.

Authors:  G S Deepe; G G Durose
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  The URA5 gene is necessary for histoplasma capsulatum growth during infection of mouse and human cells.

Authors:  D M Retallack; E L Heinecke; R Gibbons; G S Deepe; J P Woods
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  9 in total

Review 1.  The family-3 glycoside hydrolases: from housekeeping functions to host-microbe interactions.

Authors:  Denis Faure
Journal:  Appl Environ Microbiol       Date:  2002-04       Impact factor: 4.792

Review 2.  Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis.

Authors:  Jon P Woods
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

3.  Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis.

Authors:  G S Deepe; R Gibbons
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Surface localization of the Yps3p protein of Histoplasma capsulatum.

Authors:  Megan L Bohse; Jon P Woods
Journal:  Eukaryot Cell       Date:  2005-04

Review 5.  Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all.

Authors:  Jessica A Edwards; Chad A Rappleye
Journal:  FEMS Microbiol Lett       Date:  2011-08-09       Impact factor: 2.742

6.  A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis.

Authors:  Joshua D Nosanchuk; Leonardo Nimrichter; Arturo Casadevall; Marcio L Rodrigues
Journal:  Commun Integr Biol       Date:  2008

7.  Definition of the extracellular proteome of pathogenic-phase Histoplasma capsulatum.

Authors:  Eric D Holbrook; Jessica A Edwards; Brian H Youseff; Chad A Rappleye
Journal:  J Proteome Res       Date:  2011-02-25       Impact factor: 4.466

8.  Surface architecture of histoplasma capsulatum.

Authors:  Allan J Guimarães; Mariana D de Cerqueira; Joshua D Nosanchuk
Journal:  Front Microbiol       Date:  2011-11-18       Impact factor: 5.640

9.  Glycoconjugates and polysaccharides of fungal cell wall and activation of immune system.

Authors:  M R Pinto; E Barreto-Bergter; C P Taborda
Journal:  Braz J Microbiol       Date:  2008-06-01       Impact factor: 2.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.